Recent Updates
Recently added Catalysts
ALLR Negative Sentiment Score: 10/100

Allarity Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 12, 2024 Deadline to file Lead Plaintiff Motion.

Key Takeaway: Allarity Therapeutics, Inc. is facing legal challenges as the Portnoy Law Firm announces a class action for investors who purchased securities between May 17, 2022, and July 19, 2024. The firm claims that the company issued false and misleading statements about its business practices, particularly regarding regulatory issues tied to the Dovitinib NDA. Those affected have until November 12, 2024, to file a lead plaintiff motion. The allegations include misleading public statements and improper conduct related to the company’s regulatory filings, resulting in significant risks and potential damages.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investors are being encouraged to file claims due to misleading statements by Allarity Therapeutics.
  • The complaint alleges that the company exposed itself to regulatory scrutiny and potential enforcement actions.
  • Allarity's public statements regarding the Dovitinib NDA are deemed materially false and misleading.
  • The company is under investigation for wrongful activities related to its regulatory submissions.

Full Press Release Details

LOS ANGELES, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR) investors of a class action representing investors that bought securities between May 17, 2022, and July 19, 2024, inclusive (the "Class Period"). Allarity investors have until November 12, 2024 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The Complaint asserts that, throughout the Class Period, the Defendants issued materially false and misleading statements concerning the Company’s business practices, operations, and adherence to compliance policies. Specifically, it contends that the Defendants inflated the ongoing regulatory prospects of the Dovitinib NDA and engaged in illegal, illicit, or otherwise improper conduct related to the Dovitinib NDA and/or the Dovitinib-DRP PMA, involving Allarity and three of its former officers. This misconduct exposed the Company to heightened risks of regulatory and governmental scrutiny, enforcement actions, and significant legal, financial, and reputational damages. Following the disclosure that Allarity was under investigation for wrongdoing related to the Dovitinib NDA and/or Dovitinib-DRP PMA, the Company downplayed the likelihood of an enforcement action resulting from the investigation. As a result, the Company’s public statements were materially false and misleading throughout the relevant period.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising

Tags

Frequently Asked Questions

What is the deadline for filing a motion for lead plaintiff?

Investors must file a lead plaintiff motion by November 12, 2024.

What allegations are made against Allarity Therapeutics?

The complaint claims Allarity made false statements about its business practices and regulatory prospects.

How can investors contact Portnoy Law Firm?

Investors can reach Lesley F. Portnoy at 310-692-8883 or lesley@portnoylaw.com.

What were the consequences of Allarity’s alleged misconduct?

The misconduct exposed Allarity to regulatory scrutiny and potential legal damages.

What support does the Portnoy Law Firm offer investors?

The firm provides complimentary case evaluations and options for recovering losses.

Last updated: Oct 29, 2024